201 / 245
DOS Kongressen 2016 ·
201
Possible causes for lack of 1-year follow-up in
national ACL-registry
Martin Albert Lundorff, Bent Lund
Department of Orthopaedics , Horsens Regional Hospital HEH; Department of
Orthopaedics , Horsens Regional Hospital HEH
Background:
Arthroscopic reconstruction of the anterior cruciate ligament
(ACL-R) is an established treatment for rupture of the ACL. In Denmark there
are more than 2200 primary ACL-R each year. At the 1-year postoperative fol-
low-up one performs a series of measurements in order to assess the progress
of the patients and their symptoms. To have a uniform follow-up, all centres
report to the Danish National ACL- registry. A quality indicator is 1-year fol-
low- up and the cut-of is a 60% minimum. Many centres, including HEH, have
problems living up to this indicator. At HEH the numbers were 52,9% in 2012
and 63,0% in 2013.
Purpose / Aim of Study:
The aim of this study is to examine the 1- year
follow-up at HEH and possible reasons for lack of achieving this goal. Our hy-
pothesis is that the patient’s follow-up is possibly lost due to poor registration,
rebooking, cancellation, reoperation or no- show.
Materials and Methods:
Reviewing local ACL-R patient registry examining our
follow-up (2012-14).
Findings / Results:
We included 180 patients (2012-14) that had a primary
ACL-R. We found that 149 patients (82.8%) were seen for 1-year follow-up.
21 patients (14%) had been registered wrongly as they had been examined by a
surgeon instead of a physiotherapist. Thus they were not registered in the ACL-
registry. 31 patients (17.2%) were not seen for 1-year follow-up. 16 (8,8%)
because they were not called in. 15 (8.3%) got called in but did not show up
either due to rebooking, cancellation, reoperation or no-show.
Conclusions:
We have highlighted possible causes for missing 1-year follow-
up for our ACL-R patients and why we do not score higher in the registry on
this indicator. The results show that with an optimization in the registration and
booking of these patients, we will be able ensure that more patients are as-
sessed at their 1-year follow-up.
No conflicts of interest reported
152.